Ann: Positive in vitro data for CHM 1301 CAR NK cells, page-55

There is a guaranteed shortfall since hopper is limited in his holding percentage is my understanding. Hence why they added the oversubscription option in the first place.
What's intriguing to me is that it's at their discretion where they allot the extra shares so that will be interesting who winds up getting them. Bells getting the options with strike 3.8 is worth noting as well.
The NK platform looking the goods, its the one I'm most excited about here. I like how they are able to progress that platform without much cash injection from the company since different people want to investigate paring different solutions with it.